E2 ModeratePreliminaryPEM not requiredCross-SectionalPeer-reviewedMachine draft
Assessment of the Gut Microbiome in Patients with Coexisting Irritable Bowel Syndrome and Chronic Fatigue Syndrome.
Chojnacki, Marcin, Błońska, Aleksandra, Kaczka, Aleksandra et al. · Nutrients · 2025 · DOI
Quick Summary
This study looked at the gut bacteria and their byproducts in 80 women, comparing those with IBS alone to those with both IBS and chronic fatigue. Women with both conditions had different types of bacteria and different levels of certain chemicals in their urine, particularly those related to tryptophan (an amino acid). Higher levels of some of these chemicals were linked to worse fatigue symptoms.
Why It Matters
Identifying distinct microbiota and metabolite patterns in ME/CFS patients could illuminate mechanisms underlying fatigue and guide targeted microbiome-based interventions. The focus on tryptophan metabolism and neuroactive compounds connects gut biology to neurological symptoms central to ME/CFS, potentially opening new diagnostic and therapeutic avenues.
Observed Findings
- Women with IBS-CFS had greater microbial diversity (higher Shannon Diversity Index) compared to IBS-alone group
- Breath methane levels were significantly higher in the IBS-CFS group
- Urinary quinolinic acid, xanthurenic acid, 3-indoxyl sulfate, and homovanillic acid were elevated in IBS-CFS patients
- Urinary kynurenine and 5-hydroxyindoleacetic acid concentrations were lower in IBS-CFS patients
- Fatigue severity (CFQ-11/FSS scores) showed positive correlation with urinary xanthurenic acid and quinolinic acid levels
Inferred Conclusions
- Women with coexisting IBS and CFS exhibit distinct gut microbiota composition and tryptophan metabolite profiles compared to IBS without fatigue
- Neuroactive kynurenine pathway derivatives may be associated with fatigue severity in IBS-CFS patients
- The gut-brain axis dysregulation via altered microbial metabolite production may contribute to CFS pathophysiology
Remaining Questions
- What is the direction of causality—do altered microbiota and metabolites drive fatigue, or does fatigue alter microbiota composition?
- How do these microbiota and metabolite patterns compare to healthy controls without IBS or CFS?
What This Study Does Not Prove
This cross-sectional study cannot establish causation—whether altered microbiota cause metabolite changes and fatigue, or whether fatigue and illness alter the microbiota. The findings are correlational only and require validation; the authors explicitly state these are hypothesis-generating results that need further investigation before clinical application.
Tags
Symptom:Fatigue
Biomarker:MetabolomicsBlood Biomarker
Method Flag:PEM Not DefinedWeak Case DefinitionSmall SampleExploratory OnlySex-Stratified
Metadata
- DOI
- 10.3390/nu17132232
- PMID
- 40647335
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →